Form 4 for RLAY Relay Therapeutics, Inc.
Accepted 2025-11-04 00:00:00 ET · period of report 2025-11-03 · accession 0001193125-25-264700 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-04 | 2025-11-03 | RLAY | Patel Sanjiv | Pres, CEO, Dir | S - Sale | $7.00 | -62.1K | 703.2K | -8% | -$434.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-03 | S | D | 62,073 | $7.00 | 703,215 | D | — | — | (F1) Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 136,853 shares of restricted stock units ("RSUs") on October 31, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs. (F2) Includes 136,854 shares underlying RSUs. |